Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials (2023)

First Author: Voysey M
Attributed to:  The Future Vaccine Manufacturing Research Hub (Vax-Hub) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cei/uxad013

Publication URI: http://dx.doi.org/10.1093/cei/uxad013

Type: Journal Article/Review

Parent Publication: Clinical and Experimental Immunology

Issue: 3